v3.25.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net loss $ (1,700) $ (1,862)
Adjustment to reconcile net income (loss) to net cash provided by (used in) operating activities    
Depreciation & amortization 12 536
Interest expense settled by equity 316
Common stock issued for services 88
Amortization of debt discount 223 36
Other income (111)
Stock compensation expenses 36 26
(Increase)/ decrease in:    
Accounts receivable (797) 1,141
Other current assets (785) 486
Due from affiliates (1,448) 271
Accounts payable and accrued expenses (820) 60
Other current liabilities (572) (744)
Net cash used in operating activities (5,557) (50)
Cash flows from investing activities    
Net cash provided by/ (used in) investing activities
Cash flows from financing activities    
Increase/(decrease) in short term borrowing 186 (883)
Repayment of convertible note (1,500)
Proceeds from equity issuance 13,677
Net cash provided by/ (used in) financing activities 12,363 (883)
Net increase (decrease) in cash and cash equivalents 6,806 (933)
Cash and cash equivalents    
Cash and cash equivalents at the beginning of the period 20 1,234
Cash and cash equivalents at the end of the period 6,826 301
Supplementary disclosure of cash flows information    
Interest 413 149
Conversion of debt to equity $ 1,191